Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120124) titled 'A Clinical Trial to Evaluate the Clinical Therapeutic Value of 4-hour Hemoperfusion and the Influencing Factors of Its Safety in Maintenance Hemodialysis (MHD) Patients' on March 10.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Lianyungang First People's Hospital
Condition:
Hemoperfusion After Renal Injury
Intervention:
2-hour Hemoperfusion Group:Prolonging the Duration of Hemoperfusion Therapy and Adjusting the Treatment Flow Rate of Hemoperfusion Combined with Hemodialysis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-18
Ta...